CHINA-VACCINE DIPLOMACY: BAHRAIN, DUBAI AND SEYCHELLES HAVE OPTED FOR PFIZER VACCINES AS SINOPHARM VACCINES HAVE NOT PROVED EFFECTIVE

ARS Technica reported (June 6) that in Bahrain officials are now offering high-risk people who have already received two doses of China’s Sinopharm vaccine a third vaccine dose—but one made by Pfizer-BioNTech. It said Bahrain was one of the first countries to back and rollout Sinopharm’s vaccine with nearly 58 per cent of its population receiving at least one dose of the Sinopharm vaccine, but the country is now seeing its worst wave of COVID-19 yet and the government has recently issued a two-week lockdown to try to get transmission under control. Seychelles went through a similar struggle with the archipelago seeing a dramatic spike in cases in mid-May, despite having around 70 per cent of its population vaccinated with at least one dose. Seychelles too had largely relied on the Sinopharm vaccine. It said the Wall Street Journal had reported that Dubai, which has also relied on Sinopharm’s vaccine, is now quietly offering residents who have been fully vaccinated with the Sinopharm vaccine the opportunity to get re-vaccinated with the Pfizer-BioNTech vaccine.





Subscribe to Newswire | Site Map | Email Us
Centre for China Analysis and Strategy, A-50, Second Floor, Vasant Vihar, New Delhi-110057
Tel: 011 41017353
Email: office@ccasindia.org